Lattice Biologics Ltd. Reports Second Quarter 2016 Highlights - Seite 3

Lattice Biologics develops and manufactures biologic products to domestic and international markets. Lattice's products are used in a variety of surgical applications.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements herein, other than statements of historical fact, are to be considered forward looking. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "continuing", "intends" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Lattice to be materially different from those expressed by such forward-looking statements or forward-looking information. Although Lattice believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Subscribe to Lattice News Updates

Follow us on Twitter: @LatticeBio

Image Available: http://www.marketwire.com/library/MwGo/2016/5/26/11G100293/Images/Q2_Results_graphic_800_458-571d9942dc6996b282a6375734574c56.jpg

Media Contact:
Melanie Battista
Public Relations
Lattice Biologics Ltd.
(TSX VENTURE: LBL)(OTCBB: BLVKF)
16701 N 90th Street, Suite#101
Scottsdale, AZ 85260
480-563-0800 Office
[e-mail]
www.LatticeBiologics.com